CRISPR Medicine News
Business News
About CRISPR Medicine News
Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Transfusion-dependent Beta-Thalassemia, TDT, (NCT06065189)
Sponsors:
Children's Hospital of Fudan University
Sponsors:
Children's Hospital of Fudan University
IND Enabling
Phase I
Phase II
Phase III
Transfusion-dependent Beta-Thalassemia, TDT, (NCT06291961)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
Sponsors:
CorrectSequence Therapeutics Co., Ltd
IND Enabling
Phase I
Phase II
Phase III